Literature DB >> 8392647

Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro.

G Scannell1, K Waxman, G J Kaml, G Ioli, T Gatanaga, R Yamamoto, G A Granger.   

Abstract

Tissue hypoxia following hemorrhage and trauma is a possible initiating factor of the generalized inflammatory response seen after shock. The role of hypoxia in the release from a human monocyte cell line (THP-1) of tumor necrosis factor-alpha (TNF alpha) and its soluble membrane receptors (TNF alpha R) in-vitro is investigated in this study. Flat-bottom plates with 500,000 THP-1 cells/ml were placed in air-tight sealed boxes and exposed to hypoxia (O2 = 1%) or controls (O2 = 9%) for up to 24 hr. Supernatants were tested for TNF alpha, as well as 55- and 75-kDa soluble receptors for TNF alpha, by ELISA. Cell viability was assessed by vital dye uptake and was found to be maintained throughout hypoxic exposure. Medium pH levels were within normal range. In eight experiments conducted in duplicate, minimal change over 24 hr occurred in control samples. Control mean and SD were: TNF alpha = 12.0 +/- 4.2, 55-kDa R = 34.6 +/- 2.03, and 75-kDa R = 38.88 +/- 9.68 pg/ml. During hypoxia, TNF alpha was released as early as the first 30 min of exposure (41.3 +/- 2.3 pg/ml) with a small peak at 1 hr (52 +/- 5.0 pg/ml) and a later more pronounced peak at 18 hr (526 +/- 48 pg/ml). Both 55- and 75-kDa R were released by the hypoxic monocytes; release was progressive and was maximal at 24 hr in this study. Maximal release value of 55-kDa R was 236 +/- 15 pg/ml, while for 75-kDa R it was 2450 +/- 63 pg/ml.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392647     DOI: 10.1006/jsre.1993.1044

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  19 in total

1.  Early wound healing exhibits cytokine surge without evidence of hypoxia.

Authors:  Z A Haroon; J A Raleigh; C S Greenberg; M W Dewhirst
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

Review 2.  Chronic heart failure and the immune system.

Authors:  Daniela Mari; Federica Di Berardino; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

3.  Immunologic Consequences of Hypoxia during Critical Illness.

Authors:  Harmke D Kiers; Gert-Jan Scheffer; Johannes G van der Hoeven; Holger K Eltzschig; Peter Pickkers; Matthijs Kox
Journal:  Anesthesiology       Date:  2016-07       Impact factor: 7.892

Review 4.  Vascular endothelial growth factor signaling in hypoxia and inflammation.

Authors:  S Ramakrishnan; Vidhu Anand; Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2014-03-09       Impact factor: 4.147

5.  The influence of oxygen and carbon dioxide tension on the production of TNF alpha by activated macrophages.

Authors:  L E Sampson; D J Chaplin
Journal:  Br J Cancer Suppl       Date:  1996-07

6.  Inflammatory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia.

Authors:  J K Yun; T S McCormick; C Villabona; R R Judware; M B Espinosa; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

7.  Caffeine reduces TNFalpha up-regulation in human adipose tissue primary culture.

Authors:  C Dray; D Daviaud; C Guigné; P Valet; I Castan-Laurell
Journal:  J Physiol Biochem       Date:  2007-12       Impact factor: 4.158

8.  Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor.

Authors:  A D Blann; C N McCollum
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

9.  Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Effects of recombinant bactericidal/permeability-increasing protein.

Authors:  Y M Yao; S Bahrami; G Leichtfried; H Redl; G Schlag
Journal:  Ann Surg       Date:  1995-04       Impact factor: 12.969

10.  Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness.

Authors:  Banu Turgut Ozturk; Banu Bozkurt; Hurkan Kerimoglu; Mehmet Okka; Umit Kamis; Kemal Gunduz
Journal:  Mol Vis       Date:  2009-09-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.